Aldehyde Dehydrogenase-2 (Aldh2) Ameliorates Chronic Alcohol Ingestion-Induced Hepatic Steatosis And Inflammation

rui guo,jun ren

DOI: https://doi.org/10.1096/fasebj.26.1_supplement.405.8

2012-01-01

Abstract:Objectives Mitochondrial aldehyde dehydrogenase (ALDH2) plays a critical role in the detoxification of the ethanol metabolite acetaldehyde. Chronic alcohol intake has been shown to result in alcoholic liver disease although the precise mechanism of action is still elusive. This study was designed to examine the impact of global ALDH2 overexpression on chronic alcohol ingestion‐induced hepatic steatosis and inflammation. Methods FVB and ALDH2 mice were placed on a 4% alcohol or control diet for 12 weeks. Serum levels of AST/ALT and total bilirubin, levels of hepatic triglyceride, hepatic histology on steatosis, fat metabolism‐related proteins and inflammatory factors were examined. Results Chronic alcohol intake led to enhanced levels of total bilirubin and hepatic triglycerides, increased fat deposition as evidenced by H&E and Oil‐Red‐O stainings, elevated fatty acid synthase, stearoyl‐CoA desaturase 1, phospho‐acetyl‐CoA carboxylase‐1, PPAR γ, PGC‐1α, IL‐6 and phosphorylation of AMPK and Stat3, decreased phosphorylation of mTOR as well as unchanged levels of G6Pase‐α, TNF‐α and IL‐1β, the effects of which were overtly attenuated or ablated by ALDH2, with the exception of fatty acid synthase, G6Pase‐α, TNF‐α and IL‐1β expression. Conclusions In summary, our results revealed that ALDH2 may effectively ameliorate chronic alcohol ingestion‐induced hepatic steatosis and inflammation.